Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
The only human trial ever registered (NCT02637284) was cancelled in 2016 without publishing results
By recruiting additional cells from surrounding areas, BPC-157 overcomes one of the main limitations in connective tissue healing
Research suggests the use of vitamin B12 supplements in those with kidney disease and a B12 deficiency, but fully understanding the risks and benefits of regular supplemental B12 in those without a deficit still requires more research
BPC-157 is not a first-line treatment for most conditions
Each treatment should be considered under medical supervision
By accessing this website and purchasing these products, you acknowledge that you are qualified to handle research materials and agree to comply with all applicable federal, state, and local laws and regulations
US$ 28.54
US$ 22.91
US$ 24.71
US$ 21.71
US$ 22.92
US$ 27.04
US$ 26.23
US$ 22.06
US$ 27.26
US$ 27.33
US$ 26.56
US$ 22.12
US$ 21.69
US$ 21.38
